UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000016265
Receipt number	R000017324
Scientific Title	Phase II study evaluating safety and efficacy of induction therapy with small-dose bortezomib, lenalidomide and dexamethasone combination for previously untreated symptomatic multiple myeloma
Date of disclosure of the study information	2015/01/19
Last modified on	2018/07/26 19:03:59

---